Top Story

HDV inhibitor receives orphan drug designation by FDA, EMA

December 22, 2014

Eiger BioPharmaceuticals Inc. has been granted orphan drug designation by the FDA and European Medicines Agency for its drug lonafarnib for the treatment of hepatitis delta virus infection, according to a press release from the manufacturer.

With the status, Eiger will be able to market lonafarnib, an inhibitor of farnesyl transferase, exclusively and qualify for various development incentives, according to the release.

Edward Cox FDA approvals

FDA approves Zerbaxa for complicated intra-abdominal infections, UTIs

December 22, 2014
The FDA has approved a new combination antibiotic for the treatment of complicated intra-abdominal infections and complicated urinary tract infections in…
In the Journals

PEG-IFN monotherapy reduced HBsAg expression

December 22, 2014
Patients with hepatitis B virus infection who underwent monotherapy with pegylated interferon had decreased hepatitis B surface antigen expression and an increased rate…

Mothers with probable, confirmed Ebola should not breast-feed

December 22, 2014
The Association of Women’s Health, Obstetric and Neonatal Nurses recently published recommendations for the management of pregnant women with Ebola.Patients with…
In the Journals

Influenza activity low but rising nationwide

December 22, 2014
From Sept. 28 to Dec. 6, almost 125,000 respiratory specimens in the United States were tested for influenza and 10.9% were positive, according to a CDC report…
More News Headlines »
CME CNE CPE Video
Advances in Pharmacokinetic Enhancers in HIV Treatment: What You Need to Know to Optimize Outcomes

Advances in Pharmacokinetic Enhancers in HIV Treatment: What You Need to Know to Optimize Outcomes

This activity is supported by an educational grant from Bristol-Myers Squibb.

Protease inhibitors (PIs) have played an instrumental role in decreasing mortality andmorbidity among HIV-infected…
More »
Meeting News Coverage Video
thumbnail for video 3911388507001

Student education, immunization requirements necessary to prevent outbreaks on college campuses

November 28, 2014
NEW YORK — James C. Turner, MD, executive director of the department of student health and the National Social…
More »
CME
J490 Challenges in HIV Screening

Challenges in HIV Screening and Prophylaxis: PrEP’ing for the Future

This activity is supported by an educational grant from Gilead Sciences Medical Affairs.

A substantial proportion of Americans with HIV remain undiagnosed and suboptimally treated. Failure to follow…
More »
morganatic-roan
morganatic-roan